Si-Bone’s new CCO is ex-Baxano CEO Recupero
Prior to moving to Si-Bone, Recupero served as president of medical device and diganostic commercialization strategy company Catalyst Performance Advisors and CEO of Baxano Inc, as well as other executive positions in the health care field, the company said.
“I am thrilled to welcome Tony to SI-Bone at this exciting time in our company’s journey. Tony is a highly accomplished leader with a proven record of driving growth and building long-term commercial platforms, and I am confident that we can leverage his experience and knowledge to accelerate our growth. Our company is in a very exciting place, with over $20M of fresh growth capital, new products in the pipeline, improving reimbursement in the U.S. and 2-year results from our first randomized controlled trial soon to be published. I look forward to working with Tony to maximize the opportunity in front of us,” CEO Jeffrey Dunn said in a press release.